Restenosis after Coronary Angioplasty: Pathogenesis of Neointimal Thickening Initiated by Endothelial Loss

References

• Alheid U., Frolich J C., Förstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb. Res. 1987; 47: 561–571
   PubMed Web of Science ®Google Scholar
• Alitalo K., Hovi T., Vaheri A. Fibronectin is produced by human macrophages. J. Exp. Med. 1980; 151: 602–613
   PubMed Web of Science ®Google Scholar
• Alteri E., Leonard E. J. Effect of serotonin on human monocytes in short-term culture. (Abstract). Fed. Proc 1984; 43: 385
   Google Scholar
• Araki S., Kawahara Y., Kariya K., Sunato M., Tsuda T., Fukuzaki H., Takai Y. Stimulation of platelet-derived growth factor-induced DNA synthesis by angiotensin II in rabbit vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1990a; 168: 350–357
   PubMed Web of Science ®Google Scholar
• Araki S., Kawahara Y., Fukuzaki H., Takai Y. Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cells. Atherosclerosis 1990b; 83: 29–34
   PubMed Web of Science ®Google Scholar
• Asada Y., Hayashi T., Tanimura N., Kisanuki A., Sumiyoshi A. Replication of endothelial cells and smooth muscle cells inducedin vivo by hypercholesterolemia and materials released from platelet-rich white thrombus. J. Pathol. 1992; 166: 69–75
   PubMed Web of Science ®Google Scholar
• Austin G. E., Ratliff N. B., Hollman J., Tabei S., Phillips D. F. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol 1985; 6: 369–375
   PubMed Web of Science ®Google Scholar
• Azuma H., Ishikawa M., Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br. J. Pharmacol 1986; 88: 411–415
   PubMed Web of Science ®Google Scholar
• Azuma H., Funayama N., Kubota T., Ishikawa M. Regeneration of endothelial cells after balloon denudation of the rabbit carotid artery and changes in responsiveness. Jpn. J. Pharmacol 1990; 52: 541–552
   PubMedGoogle Scholar
• Bagby S. P., O'Reilly M. M., Kirk E. A., Mitchell L. H., Stenberg P. E., Makler M. T., Bakke A. C. EGF is incomplete mitogen in porcine aortic smooth muscle cells: DNA synthesis without cell division. Am.J. Physiol. 1992; 262: C578–C588
   PubMed Web of Science ®Google Scholar
• Banskota N. K., Taub R., Zellner K., King G. L. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol. Endocrinol. 1989; 3: 1183–1190
   PubMed Web of Science ®Google Scholar
• Barath P., Fishbein MC., Cao J., Berenson J., Helfant R. H., Forrester J. S. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 1990; 65: 297–302
   PubMed Web of Science ®Google Scholar
• Barrett T. B., Benditt E. P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. USA 1988; 85: 2810–2814
   PubMed Web of Science ®Google Scholar
• Barrett T. B., Gajdusek C. M., Schwartz S. M., McDougall J. K., Benditt E. P. Expression of thesis gene by endothelial cells in culture and in vivo. Proc. Natl. Acad. Sci. USA 1984; 81: 6772–6774
   PubMed Web of Science ®Google Scholar
• Bar-Shavit R., Kahn A., Fenton J. W., II, Wilner G. D. Chemotactic response of monocytes to thrombin. J. Cell. Biol. 1983; 96: 282–285
   PubMed Web of Science ®Google Scholar
• Battegay E. J., Raines E. W., Seifert R. A., Bowen-Pope D. F., Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515–524
   PubMed Web of Science ®Google Scholar
• Bell L., Madri J. A. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 1989; 65: 1057–1065
   PubMed Web of Science ®Google Scholar
• Bell L., Madri J. A. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am. J. Pathol 1990; 137: 7–12
   PubMed Web of Science ®Google Scholar
• Berk BC., Vekshtein V., Gordon H. M., Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13: 305–314
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Wheeler M. E., Cotran R. S., Gimbrone M. A., Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest 1985; 76: 2003–2011
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Schleef R. R., Gimbrone M. A., Jr., Loskutoff D. J. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J. Clin. Invest. 1986a; 78: 587–591
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Majeau G. R., Fiers W., Cotran R. S., Gimbrone M. A., Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the action of interleukin 1. Proc. Natl. Acad. Sci. USA 1986b; 83: 4533–4537
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Mendrick D. L., Cotran R. S., Gimbrone M. A., Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 1987; 84: 9238–9242
   PubMed Web of Science ®Google Scholar
• Birdwell C. R., Gospodarowicz D., Nicolson G. L. Identification, localization, and role of fibronectin in cultured bovine endothelial cells. Proc. Natl. Acad. Sci. USA 1978; 75: 3273–3277
   PubMed Web of Science ®Google Scholar
• Biro S., Siegall C. B., Fu Y.-M., Speir E., Pastan I., Epstein S. E. In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells. Circ. Res. 1992; 71: 640–645
   PubMed Web of Science ®Google Scholar
• Bizios R., Lai LC., Cooper J. A., Del Vecchio P. J., Malik A. B. Thrombin-induced adherence of neutrophils to cultured endothelial monolayers: Increased endothelial adhesiveness. J. Cell Physiol. 1988; 134: 275–280
   PubMed Web of Science ®Google Scholar
• Björkerud S. Impaired fibrinolysis-inducing capacity for postinjury phenotype of cultivated human arterial and human atherosclerotic intimal smooth muscle cell. Ore. Res 1988; 62: 1011–1018
   Google Scholar
• Björkerud S. Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro. Arterioscler. Thromb. 1991; 11: 892–902
   PubMedGoogle Scholar
• Bjornsson T. D., Dryjski M., Tluczek J., Mennie R., Ronan J., Mellin T. N., Thomas K. A. Acidic fibroblast growth factor promotes vascular repair. Proc. Natl. Acad. Sci. USA 1991; 88: 8651–8655
   PubMed Web of Science ®Google Scholar
• Blackshear J. L., O'Callaghan W. G., Califf R. M. Medical approaches to prevention of restenosis after coronary angioplasty. J. Am. Coll. Cardiol 1987; 9: 834–848
   PubMed Web of Science ®Google Scholar
• Boogaerts M. A., Yamada O., Jacob H. S., Moldow C. F. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc. Natl. Acad. Sci. USA 1982; 79: 7019–7023
   PubMed Web of Science ®Google Scholar
• Border W. A., Ruoslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J. Clin. Invest. 1992; 90: 1–7
   PubMed Web of Science ®Google Scholar
• Bornfeldt K. E., Arnqvist H. J., Norstedt G. Regulation of insulin-like growth factor-1 gene expression by growth factors in cultured vascular smooth muscle cells. J. Endocrinol 1990; 125: 381–386
   PubMed Web of Science ®Google Scholar
• Bornfeldt K. E., Arnqvist H. J., Capron L. In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin. Diabetologia 1992; 35: 104–108
   PubMed Web of Science ®Google Scholar
• Bowen-Pope D. F., Hart C. E., Seifert R. A. Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J. Biol. Chem. 1989; 264: 2502–2508
   PubMed Web of Science ®Google Scholar
• Brezinski D. A., Nesto R. W., Serhan C. N. Angioplasty triggers intracoronary leukotrienes and lipoxin A4: Impact of aspirin therapy. Circulation 1992; 86: 56–63
   PubMed Web of Science ®Google Scholar
• Caldwell P. R. B., Seegal B. C., Hsu KC., Das M., Soffer R. L. Angiotensin-converting enzyme: Vascular endothelial localization. Science 1976; 191: 1050–1051
   PubMed Web of Science ®Google Scholar
• Carrozza J. P., Jr, Kuntz R. E., Levine M. J., Pomerantz R. M., Fishman R. F., Mansour M., Gibson C. M., Senerchia Diver C. C., Safian D. J. R. D., Bairn D. S. Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience. J. Am. Coll. Cardiol 1992; 20: 328–337
   PubMed Web of Science ®Google Scholar
• Cascieri M. A., Chicchi G. G., Hayes N. S., Slater E. E. Stimulation of DNA synthesis in rat A10 vascular smooth muscle cells by threonine-59 insulin-like growth factor I. Circ. Res. 1986; 59: 171–177
   PubMed Web of Science ®Google Scholar
• Casscells W. Migration of smooth muscle and endothelial cells: Critical events in restenosis. Circulation 1992; 86: 723–729
   PubMed Web of Science ®Google Scholar
• Casscells W., Lappi D. A., Olwin B. B., Wai C, Siegman M., Speir E. H., Sasse J., Baird A. Elimination of smooth muscle cells in experimental restenosis: Targeting of fibroblast growth factor receptors. Proc. Natl. Acad. Sci. USA 1992; 89: 7159–7163
   PubMed Web of Science ®Google Scholar
• Castellot J. J., Jr, Wright T. C., Karnovsky M. J. Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates. Semin. Thromb. Hemost 1987; 13: 489–503
   PubMed Web of Science ®Google Scholar
• Cercek B., Fishbein MC., Forrester J. S., Helfant R. H., Fagin A. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ. Res. 1990; 66: 1755–1760
   PubMed Web of Science ®Google Scholar
• Clancy R. M., Leszczynska-Piziak J., Abramson S. B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on theNADPH oxidase. J. Clin. Invest. 1992; 90: 1116–1121
   PubMed Web of Science ®Google Scholar
• Clemmons D. R. Interaction of circulating cell-derived and plasma growth factors in stimulating cultured smooth muscle cell replication. J. Cell. Physiol. 1984; 121: 425–430
   PubMed Web of Science ®Google Scholar
• Clemmons D. R. Variables controlling the secretion of a somatomedin-like peptide by cultured porcine smooth muscle cells. Circ. Res. 1985; 56: 418–426
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Karnovsky M. J. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265: 625–626
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Collazzo R. E., Karnovsky M. J. Amor-phologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab. Invest. 1978; 39: 141–150
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Reidy M. A., Clowes M. M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 1983a; 49: 327–333
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Reidy M. A., Clowes M. M. Mechanisms of stenosis after arterial injury. Lab. Invest. 1983b; 49: 208–215
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Clowes M. M., Reidy M. A. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab. Invest. 1986; 54: 295–303
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Clowes M. M., Fingerle J., Reidy M. A. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab. Invest. 1989a; 60: 360–364
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Clowes M. M., Fingerle J., Reidy M. A. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc. Pharmacol 1989b; 14: S12–S14, Suppl. 6
   PubMed Web of Science ®Google Scholar
• Clowes A. W., Clowes M. M., Au Y. P. T., Reidy M. A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ. Res. 1990; 67: 61–67
   PubMed Web of Science ®Google Scholar
• Cocks T. M., Manderson J. A., Mosse P. R. L., Campbell G. R., Angus J. A. Development of a large fibromuscular intimal thickening does not impair endothelium-dependent relaxation in the rabbit carotid artery. Blood Vessels 1987; 24: 192–200
   PubMedGoogle Scholar
• Coghlan J. G., Flitter W. D., Holley A. E., Norell M., Mitchell A. G., Ilsley C. D., Slater T. F. Detection of free radicals and cholesterol hydroperoxides in blood taken from the coronary sinus of man during percutaneous transluminal coronary angioplasty. Free. Radic. Res. Commun. 1992; 14: 409–417
   Google Scholar
• Cooper J. A., Lo S. K., Malik A. B. Fibrin is a determinant of neutrophil sequestration in the lung. Circ. Res. 1988; 63: 735–741
   PubMed Web of Science ®Google Scholar
• Daemen M. J. A. P., Lombardi D. M., Bosman F. T., Schwartz S. M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 1991; 68: 450–456
   PubMed Web of Science ®Google Scholar
• Daniel T. O., Fen Z. Distinct pathways mediate transcriptional regulation of platelet-derived growth factor B/ c-sts expression. J. Biol. Chem. 1988; 263: 19815–19820
   PubMed Web of Science ®Google Scholar
• Daniel T. O., Gibbs V. C., Milfay D. F., Williams L. T. Agents that increase cAMP accumulation block endothelial c-si's induction by thrombin and transforming growth factor-β. J. Biol. Chem. 1987; 262: 11893–11896
   PubMed Web of Science ®Google Scholar
• de Bono D. P., Green C. The adhesion of different cell types to cultured vascular endothelium: Effects of culture density and age. Br. J. Exp. Pathol. 1984; 65: 145–154
   PubMed Web of Science ®Google Scholar
• de Graaf JC., Banga J. D., Moncada S., Palmer R. M. J., de Groot P. G., Sixma J. J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284–2290
   PubMed Web of Science ®Google Scholar
• De Servi S., Mazzone A., Ricevuti G., Fioravanti A., Bramucci E., Angoli L., Stefano G., Specchia G. Granulocyte activation after coronary angioplasty in humans. Circulation 1990; 82: 140–146
   PubMed Web of Science ®Google Scholar
• Delafontaine P., Lou H., Alexander R. W. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 1991a; 18: 742–747
   PubMed Web of Science ®Google Scholar
• Delafontaine P, Bernstein K. E., Alexander R. W. Insulin-like growth factor I gene expression in vascular cells. Hypertension 1991b; 17: 693–699
   PubMed Web of Science ®Google Scholar
• Deuel T. F., Senior R. M., Huang J. S., Griffin G. L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest. 1982; 69: 1046–1049
   PubMed Web of Science ®Google Scholar
• DiCorleto P. E., de la Motte C. A. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J. Clin. Invest. 1985; 75: 1153–1161
   PubMed Web of Science ®Google Scholar
• DiCorleto P. E., Chisolm G. M., III. Participation of the endothelium in the development of the atherosclerotic plaque. Prog. Lipid Res. 1986; 25: 365–374
   PubMed Web of Science ®Google Scholar
• Dzau V. J., Gibbons G. H., Pratt R. E. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 1991; 18: II-100–II-105, Suppl. II
   Web of Science ®Google Scholar
• Eldor A., Falcone D. J., Hajjar D. P., Minick C. R., Weksler B. B. Recovery of prostacyclin production by de-endothelialized rabbit aorta. J. Clin. Invest. 1981; 67: 735–741
   PubMed Web of Science ®Google Scholar
• Epstein S. E., Siegall C. B., Biro S., Fu Y., Fitz M., Gerald D., Pastan I. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation 1991; 84: 778–787
   PubMed Web of Science ®Google Scholar
• Fager G., Camejo G., Bondjers G. Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin. In Vitro Cell Dev. Biol. 1992; 28A: 168–175
   PubMed Web of Science ®Google Scholar
• Feigl E. O. EDRF - A protective factor?. Nature 1988; 331: 490–491
   PubMed Web of Science ®Google Scholar
• Feinmark S. J., Cannon P. J. Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J. Biol. Chem. 1986; 261: 16466–16472
   PubMed Web of Science ®Google Scholar
• Ferns G. A. A., Raines E. W., Sprugel K. H., Motani A. S., Reidy M. A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129–1132
   PubMed Web of Science ®Google Scholar
• Ferns G. A. A., Stewart-Lee A. L., Anggard E. E. Arterial response to mechanical injury: Balloon catheter de-endothelialization. Atherosclerosis 1992; 92: 89–104
   PubMed Web of Science ®Google Scholar
• Fingerle J., Johnson R., Clowes A. W., Majesky M. W., Reidy M. A. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc. Natl. Acad. Sci. USA 1989; 86: 8412–8416
   PubMed Web of Science ®Google Scholar
• Forrester J. S., Fishbein M., Helfant R., Fagin J. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J. Am. Coll. Cardiol. 1991; 17: 758–769
   PubMed Web of Science ®Google Scholar
• Fox P. L., DiCorleto P. E. Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells. J. Cell. Physiol 1984; 121: 298–308
   PubMed Web of Science ®Google Scholar
• Friedman R. J., Stemerman M. B., Wenz B., Moore S., Gauldie J., Gent M., Tiell M. L., Spaet T. H. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: Smooth muscle cell proliferation and re-endothelialization. J.Clin. Invest. 1977; 60: 1191–1201
   PubMed Web of Science ®Google Scholar
• Fritze L. M. S., Reilly C. F., Rosenberg R. D. An antiproliferative heparan sulfate species produced by post-confluent smooth muscle cells. J. Cell Biol 1985; 100: 1041–1049
   PubMed Web of Science ®Google Scholar
• Gajdusek C. M., Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J. Cell. Physiol 1989; 139: 570–579
   PubMed Web of Science ®Google Scholar
• Garratt K. N., Edwards W. D., Kaufmann U. P., Vlietstra R. E., Holmes D. R., Jr. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: Analysis of tissue obtained from 73 patients by directional atherectomy. J. Am. Coll Cardiol 1991; 17: 442–448
   PubMed Web of Science ®Google Scholar
• Gay C. G., Winkles J. A. Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J. Biol. Chem. 1990; 265: 3284–3292
   PubMed Web of Science ®Google Scholar
• Gay C. G., Winkles J. A. Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 1991; 88: 296–300
   PubMed Web of Science ®Google Scholar
• Geisterfer A. A. T., Peach M. J., Owens G. K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 1988; 62: 749–756
   PubMed Web of Science ®Google Scholar
• Gibbons G. H., Pratt R. E., Dzau V. J. Angiotensin II (Ang II) is a bifunctional vascular smooth muscle cell (VSMC) growth factor. (Abstract). Hypertension 1989; 14: 358
   Web of Science ®Google Scholar
• Gibbons G. H., Pratt R. E., Dzau V. J. Transforming growth factor-beta (TGF-β) expression modulates the bifunctional growth response of vascular smooth muscle cell (VSMC) to angiotensin (AH). (Abstract). Clin. Res. 1990; 38: 287A
   Google Scholar
• Gibbons G. H., Pratt R. E., Dzau V. J. Vascular smooth muscle cell hypertrophy vs. hyperplasia: Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J. Clin. Invest. 1992; 90: 456–461
   PubMed Web of Science ®Google Scholar
• Goldberg I. D., Stemerman M. B., Schnipper L. E., Ransil B. J., Crooks G. W., Fuhro R. L. Vascular smooth muscle cell kinetics: A new assay for studying patterns of cellular proliferation in vivo. Science 1979; 205: 920–922
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Brown K. D., Birdwell C. R., Zetter B. R. Control of proliferation of human vascular endothelial cells: Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J. Cell Biol 1978; 77: 774–788
   PubMed Web of Science ®Google Scholar
• Gravanis M. B. The enigma of restenosis after percutaneous transluminal coronary angioplasty. Am. J. Cardiovasc. Pathol 1988; 2: 1–5
   PubMedGoogle Scholar
• Gravanis M. B., Roubin G. S. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: The problem of restenosis. Hum. Pathol 1989; 20: 477–485
   PubMed Web of Science ®Google Scholar
• Hahn A. W. A., Ferracin F., Buhler F. R., Pletscher A. Modulation of gene expression by high and low density lipoproteins in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1991; 178: 1465–1471
   PubMed Web of Science ®Google Scholar
• Hammacher A., Hellman U., Johnsson A., Ostman A., Gunnarsson K., Westermark B., Wasteson A., Heldin C.-H. A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J. Biol. Chem. 1988; 263: 16493–16498
   PubMed Web of Science ®Google Scholar
• Handin R. I., Karabin R., Boxer G. J. Enhancement of platelelet function by superoxide anion. J. Clin. Invest. 1977; 59: 959–965
   PubMed Web of Science ®Google Scholar
• Hansson H.-A., Jennische E., Skottner A. Regenerating endothelial cells express insulin-like growth factor-I immuno-reactivity after arterial injury. Cell Tissue Res. 1987; 250: 499–505
   PubMed Web of Science ®Google Scholar
• Harlan J. M., Thompson P. J., Ross R. R., Bowen-Pope D. F. or-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J. Cell Biol 1986; 103: 1129–1133
   PubMed Web of Science ®Google Scholar
• Harrison D. G. Endothelial modulation of vascular tone: Relevance to coronary angioplasty and restenosis. J. Am. Coll. Cardiol 1991; 17: 71B–76B
   PubMed Web of Science ®Google Scholar
• Hasegawa N., Yamamoto M., Yamamoto K. Stimulation of cell growth and inhibition of prostacyclin production by heparin in human umbilical vein endothelial cells. J. Cell. Physiol 1988; 137: 603–607
   PubMed Web of Science ®Google Scholar
• Hasson J. E., Wiebe D. H., Sharefkin J. B., Abbott W. M. Migration of adult human vascular endothelial cells: Effect of extracellular matrix proteins. Surgery 1986; 100: 384–391
   PubMed Web of Science ®Google Scholar
• Hinohara T., Robertson GC., Selmon M. R., Vetter J. W., Rowe M. H., Braden L. J., McAuley B. J., Sheehan D. J., Simpson J. B. Restenosis after directional coronary atherectomy. J. Am. Coll. Cardiol 1992; 20: 623–632
   PubMed Web of Science ®Google Scholar
• Hirata Y., Takagi Y., Fukuda Y., Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225–228
   PubMed Web of Science ®Google Scholar
• Holmes D. R., Jr, Vlietstra R. E., Smith H. C., Vetrovec G. W., Kent K. M., Cowley M. J., Faxon D. P., Gruentzig A. R., Kelsey S. F., Detre K. M., Van Raden M. J., Mock M. B. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am. J. Cardiol 1984; 53: 77C–81C
   PubMed Web of Science ®Google Scholar
• Hosang M., Rouge M. Human vascular smooth muscle cells have at least two distinct PDGF receptors and can secret PDGF-AA. J. Cardiovasc. Pharmacol 1989; 14: S22–S26, Suppl. 6
   PubMed Web of Science ®Google Scholar
• Huang C.-L., Ives H. E. Growth inhibition by protein kinase C late in mitogenesis. Nature 1987; 329: 849–850
   PubMed Web of Science ®Google Scholar
• Huber K., Jörg M., Probst P., Schuster E., Lang I., Kaindl F., Binder BR. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis. Thromb. Haemost. 1992; 67: 209–213
   PubMed Web of Science ®Google Scholar
• Hutchinson H. G., Shi Y., Sigman S., Jiang L., Saini U., Zalewski A. Inhibition of human vascular smooth muscle cell proliferation usingc-myc antisense oligonucleotides. (Abstract). Circulation 1992; 86: 1–226
   PubMedGoogle Scholar
• Hwang D. L., Latus L. J., Lev-Ran A. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-β) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp. Cell Res. 1992; 200: 358–360
   PubMed Web of Science ®Google Scholar
• Ignotz R. A., Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Imai T., Hirata Y., Emori T., Yanagisawa M., Masaki T., Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19: 753–757
   PubMed Web of Science ®Google Scholar
• Ingerman-Wojenski C. M., Silver M. J. Model system to study interaction of platelets with damaged arterial wall. II. Inhibition of smooth muscle cell proliferation by dipyridamole and AH-P719. Exp. Mol. Pathol 1988; 48: 116–134
   PubMed Web of Science ®Google Scholar
• Isaacs J., Savion N., Gospodarowicz D., Shuman M. A. Effect of cell density on thrombin binding to a specific site on bovine vascular endothelial cells. J. Cell Biol 1981; 90: 670–674
   PubMed Web of Science ®Google Scholar
• Ishimitsu T., Uehara Y., Ishii M., Sugimoto T. Enhanced generation of vascular thromboxane A2 in spontaneously hypertensive rats and its role in the rapid proliferation of vascular smooth muscle cells. Am. J. Hypertens. 1988; 1: 38S–40S
   PubMed Web of Science ®Google Scholar
• Janat M. F., Liau G. Transforming growth factor 01 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J. Cell. Physiol 1992; 150: 232–242
   PubMed Web of Science ®Google Scholar
• Janoff A., Zeligs J. D. Vascular injury and lysis of basement membranein vitro by neutral protease of human leukocytes. Science 1968; 161: 702–704
   PubMed Web of Science ®Google Scholar
• Johnson A. R., Erdos E. G. Metabolism of vasoactive peptides by human endothelial cells in culture: Angiotensin I converting enzyme (kininase II) and angiotensinase. J. Clin. Invest. 1977; 59: 684–695
   PubMed Web of Science ®Google Scholar
• Johnson D. E., Hinohara T., Selmon M. R., Braden L. J., Simpson J. B. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: A histopathologic study. J. Am. Coll Cardiol 1990; 15: 419–425
   PubMed Web of Science ®Google Scholar
• Karey K. P., Sirbasku D. A. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the or-granule and release in response to thrombin. Blood 1989; 74: 1093–1100
   PubMed Web of Science ®Google Scholar
• Karey K. P., Marquardt H., Sirbasku D. A. Human platelet-derived mitogens. I. Identification of insulinlike growth factors I and II by purification and Nα amino acid sequence analysis. Blood 1989; 74: 1084–1092
   PubMed Web of Science ®Google Scholar
• Kariya K., Fukumoto Y., Tsuda T., Yamamoto T., Kawahara Y., Fukuzaki H., Takai Y. Antiproliferative action of protein kinase C in cultured rabbit aortic smooth muscle cells. Exp. Cell Res. 1987; 173: 504–514
   PubMed Web of Science ®Google Scholar
• Kariya K., Kawahara Y., Araki S., Fukuzaki H., Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1989; 80: 143–147
   PubMed Web of Science ®Google Scholar
• Karsch K. R., Haase K. K., Wehrmann M., Hassenstein S., Hanke H. Smooth muscle cell proliferation and restenosis after stand alone coronary excimer laser angioplasty. J. Am. Coll. Cardiol 1991; 17: 991–994
   PubMed Web of Science ®Google Scholar
• Katusic Z. S., Vanhoutte P. M. Superoxide anion is an endothelium-derived contracting factor. Am. J. Physiol 1989; 257: H33–H37
   PubMed Web of Science ®Google Scholar
• Key N. S., Piatt J. L., Vercellotti G. M. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arteriosder. Thromb. 1992; 12: 836–842
   PubMedGoogle Scholar
• King J. F., Manley C., Al-Wathiqui M. H. Restenosis after angioplasty: Mechanisms and clinical experience. Cardiol Clin. 1989; 7: 853–864
   PubMedGoogle Scholar
• Kinlough-Rathbone R. L., Packham M. A., Mustard J. F. Vessel injury, platelet adherence, and platelet survival. Arteriosclerosis 1983; 3: 529–546
   PubMedGoogle Scholar
• Kinsella M. G., Wight T. N. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J. Cell Biol 1986; 102: 679–687
   PubMed Web of Science ®Google Scholar
• Komuro I., Kurihara H., Sugiyama T., Takaku F., Yazaki Y. Endothelin stimulatesc-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett. 1988; 238: 249–252
   PubMed Web of Science ®Google Scholar
• Koo E. W. Y., Gotlieb A. I. Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. Am. J. Pathol 1989; 134: 497–503
   PubMed Web of Science ®Google Scholar
• Koo E. W. Y., Gotlieb A. I. Neointimal formation in the porcine aortic organ culture. 1. Cellular dynamics over 1 month. Lab. Invest. 1991; 64: 743–753
   PubMed Web of Science ®Google Scholar
• Koyama N., Koshikawa T., Morisaki N., Saito Y., Yoshida S. Secretion of a potent new migration factor for smooth muscle cells (SMC) by cultured SMC. Atherosclerosis 1991; 86: 219–226
   PubMed Web of Science ®Google Scholar
• Kramer R. H., Vogel K. G., Nicolson G. L. Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. J. Biol. Chem. 1982; 257: 2678–2686
   PubMed Web of Science ®Google Scholar
• Kurihara H., Yoshizumi M., Sugiyama T., Takaku F., Yanagisawa M., Masaki T., Hamaoki M., Kato H., Yazaki Y. Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989; 159: 1435–1440
   PubMed Web of Science ®Google Scholar
• Laiho M., Saksela O., Keski-Oja J. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor: Pericellular deposition and sensitivity to exogenous urokinase. J. Biol. Chem. 1987; 262: 17467–17474
   PubMed Web of Science ®Google Scholar
• Langeler E. G., Van Hinsbergh V. W. M. Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: Role of cAMP. Am. J. Physiol 1991; 260: C1052–C1059
   PubMed Web of Science ®Google Scholar
• Laposata M., Dovnarsky D. K., Shin H. S. Thrombin-induced gap formation in confluent endothelial cell monolayersin vitro. Blood 1983; 62: 549–556
   PubMed Web of Science ®Google Scholar
• Lee G., Mason D. T. Excimer coronary laser angioplasty: It's time for a critical evaluation. Am. J. Cardiol 1992; 69: 1640–1643
   PubMed Web of Science ®Google Scholar
• Leimgruber P. P., Roubin G. S., Hollman J., Cotsonis G. A., Meier B., Douglas J., King S., Ill S. B., Gruentzig A. R. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986; 73: 710–717
   PubMed Web of Science ®Google Scholar
• Leung D. W., Cachianes G., Kuang W.-J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• Libby P., Ordovas J. M., Birinyi L. K., Anger K. R., Dinarello C. A. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J. Clin. Invest. 1986; 78: 1432–1438
   PubMed Web of Science ®Google Scholar
• Libby P., Stephen J., Warner C, Ch M. B. B., Salomon R. N., Birinyi L. K. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N. Engl. J Med. 1988; 318: 1493–1498
   PubMed Web of Science ®Google Scholar
• Lindner V., Reidy M. A., Fingerle J. Regrowth of arterial endothelium: Denudation with minimal trauma leads to complete endothelial cell regrowth. Lab. Invest. 1989; 61: 556–563
   PubMed Web of Science ®Google Scholar
• Lindner V., Majack R. A., Reidy M. A. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J. Clin. Invest. 1990; 85: 2004–2008
   PubMed Web of Science ®Google Scholar
• Lindner V., Reidy M. A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 1991; 88: 3739–3743
   PubMed Web of Science ®Google Scholar
• Lindner V., Lappi D. A., Baired A., Majack R. A., Reidy M. A. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 1991; 68: 106–113
   PubMed Web of Science ®Google Scholar
• Liu M. W., Roubin G. S., King S. B., III. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374–1387
   PubMed Web of Science ®Google Scholar
• Lotner G. Z., Lynch J. M., Betz S. J., Henson P. M. Human neutrophil-derived platelet activating factor. J. Immunol 1980; 124: 676–684
   PubMed Web of Science ®Google Scholar
• MacDonald R. G., Henderson M. A., Hirshfeld J. W., Jr., Goldberg S. H., Bass T., Vetrovec G., Cowley M., Taussig A., Whitworth H., Margolis J. R., Hill J. A., Jugo R., Pepine C. J. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty: A report from the M-HEART Group. Am. J. Cardiol 1990; 66: 926–931, for the M-HEART Group.
   PubMed Web of Science ®Google Scholar
• Madri J. A., Dreyer B., Pitlick F. A., Furthmayr H. The collagenous components of the subendothelium: Correlation of structure and function. Lab. Invest. 1980; 43: 303–315
   PubMed Web of Science ®Google Scholar
• Madri J. A., Reidy M. A., Kocher O., Bell L. Endothelial cell behavior after denudation injury is modulated by transforming growth factor-β 1 and fibronectin. Lab. Invest. 1989; 60: 755–765
   PubMed Web of Science ®Google Scholar
• Majack R. A., Cook S. C., Bornstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J. Cell Biol 1985; 101: 1059–1070
   PubMed Web of Science ®Google Scholar
• Majack R. A. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell Biol 1987; 105: 465–471
   PubMed Web of Science ®Google Scholar
• Majack R. A., Goodman L. V., Dixit V. M. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol 1988; 106: 415–422
   PubMed Web of Science ®Google Scholar
• Majack R. A., Majesky M. W., Goodman L. V. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J. Cell Biol 1990; 111: 239–247
   PubMed Web of Science ®Google Scholar
• Majesky M. W., Benditt E. P., Schwartz S. M. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis-genes in rat aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 1988; 85: 1524–1528
   PubMed Web of Science ®Google Scholar
• Majesky M. W., Reidy M. A., Bowen-Pope D. F., Hart C. E., Wilcox J. N., Schwartz S. M. PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol 1990; 111: 2149–2158
   PubMed Web of Science ®Google Scholar
• Majesky M. W., Lindner V., Twardzik D. R., Schwartz S. M., Reidy M. A. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 1991; 88: 904–910
   PubMed Web of Science ®Google Scholar
• Matsubara T., Ziff M. Superoxide anion release by human endothelial cells: Synergism between a phorbol ester and a calcium ionophore. J. Cell. Physiol 1986; 127: 207–210
   PubMed Web of Science ®Google Scholar
• Mehta J., Dinerman J., Mehta P., Saldeen T. G. P., Lawson D., Donnelly W. H., Wallin R. Neutrophil function in ischemic heart disease. Circulation 1989; 79: 549–556
   PubMed Web of Science ®Google Scholar
• Miano J. M., Tota R. R., Vlasic N., Danishefsky K. J., Stemerman M. B. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am. J. Pathol 1990; 137: 761–765
   PubMed Web of Science ®Google Scholar
• Morisaki N., Kanzaki T., Motoyama N., Saito Y., Yoshida S. Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2 in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1988; 71: 165–171
   PubMed Web of Science ®Google Scholar
• Morisaki N., Koyama N., Mori S., Kanzaki T., Koshikawa T., Saito Y., Yoshida S. Effects of smooth muscle cell derived growth factor (SDGF) in combination with other growth factors on smooth muscle cells. Atherosclerosis 1989; 78: 61–67
   PubMed Web of Science ®Google Scholar
• Morisaki N., Kawano M., Koyama N., Koshikawa T., Umemiya K., Saito Y., Yoshida S. Effects of transforming growth factor-β1 on growth of aortic smooth muscle cells: Influences of interaction with growth factors, cell state, cell phenotype, and cell cycle. Atherosclerosis 1991; 88: 227–234
   PubMed Web of Science ®Google Scholar
• Morishita H., Hattori R., Aoyama T., Kawai C., Yui Y. The intracoronary administration of urokinase following direct PTCA for acute myocardial infarction reduces early restenosis. Am. Heart. J. 1992; 123: 1153–1156
   PubMed Web of Science ®Google Scholar
• Mueller S. N., Thomas K. A., Di Salvo J., Levine E. M. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro. J. Cell. Physiol 1989; 140: 439–448
   PubMed Web of Science ®Google Scholar
• Muller D. W. M., Ellis S. G., Topol E. J. Experimental models of coronary artery restenosis. J. Am. Coll. Cardiol 1992a; 19: 418–432
   PubMed Web of Science ®Google Scholar
• Muller D. W. M., Topol E. J., Abrams G. D., Gallagher K. P., Ellis S. G. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J. Am. Coll. Cardiol 1992b; 20: 460–466
   PubMed Web of Science ®Google Scholar
• Müller G., Behrens J., Nussbaumer U., Bohlen P., Birchmeier W. Inhibitory action of transforming growth factor O on endothelial cells. Proc. Natl. Acad. Sci. USA 1987; 84: 5600–5604
   PubMed Web of Science ®Google Scholar
• Munro J. M., Cotran R. S. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab. Invest. 1988; 58: 249–261
   PubMed Web of Science ®Google Scholar
• Naftilan A. J., Pratt R. E., Eldridge C. S., Lin H. L., Dzau V. J. Angiotensin II inducesc-fos expression in smooth muscle via transcriptional control. Hypertension 1989a; 13: 706–711
   PubMed Web of Science ®Google Scholar
• Naftilan A. J., Pratt R. E., Dzau V. J. Induction of platelet-derived growth factor A-chain andc-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 1989b; 83: 1419–1424
   PubMed Web of Science ®Google Scholar
• Naftilan A. J., Gilliland G. K., Eldridge C. S., Kraft A. S. Induction of the proto-oncogenec-jun by angiotensin II. Mol. Cell. Biol 1990; 10: 5536–5540
   PubMed Web of Science ®Google Scholar
• Naito M., Hayashi T., Kuzuya M., Funaki C, Asai K., Kuzuya F. Fibrinogen is chemotactic for vascular smooth muscle cells. FEBS Lett. 1989; 247: 358–360
   PubMed Web of Science ®Google Scholar
• Nakaki T., Nakayama M., Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol 1990; 189: 347–353
   PubMed Web of Science ®Google Scholar
• Nakao J., Ito H., Ooyama T., Chang W.-C., Murota S. Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid: Effects of A23187, nicardipine and trifluoperazine. Atherosclerosis 1983; 46: 309–319
   PubMed Web of Science ®Google Scholar
• Nakao J., Ito H., Kanayasu T., Murota S. Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid and its modulation by elevated extracellular glucose levels. Diabetes 1985; 34: 185–191
   PubMed Web of Science ®Google Scholar
• Nakao-Hayashi J., Ito H., Kanayasu T., Morita I., Murota S. Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. Atherosclerosis 1992; 92: 141–149
   PubMed Web of Science ®Google Scholar
• Nemecek G. M., Coughlin S. R., Handley D. A., Moskowitz M. A. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. USA 1986; 83: 674–678
   PubMed Web of Science ®Google Scholar
• Nilsson J., Sjolund M., Palmberg L., Thyberg J., Heldin C.-H. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. USA 1985; 82: 4418–4422
   PubMed Web of Science ®Google Scholar
• Nobuyoshi M., Kimura T., Ohishi H., Horiuchi H., Nosaka H., Hamasaki N., Yokoi H., Kim K. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J. Am. Coll. Cardiol 1991; 17: 433–439
   PubMed Web of Science ®Google Scholar
• Nomoto A., Mutoh S., Hagihara H., Yamaguchi I. Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine. Atherosclerosis 1988; 72: 213–219
   PubMed Web of Science ®Google Scholar
• Norris D. A., Clark R. A. F., Swigart L. M., Huff JC., Weston W. L., Howell S. E. Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J. Immunol 1982; 129: 1612–1618
   PubMed Web of Science ®Google Scholar
• Ohlstein E. H., Storer B. L., Butcher J. A., Debouck C., Feuerstein G. Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Ore. Res. 1991; 69: 832–841
   Google Scholar
• Okamoto S., Inden M., Setsuda M., Konishi T., Nakano T. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am. Heart J. 1992; 123: 1439–1444
   PubMed Web of Science ®Google Scholar
• O'Keefe J. H., Jr, Giorgi L. V., Hartzler G. O., Good T. H., Ligon R. W., Webb D. L., McCallister B. D. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am. J. Cardiol 1991; 67: 373–376
   PubMed Web of Science ®Google Scholar
• Orlandi C, Singh J. P., Bell F. P., Schaub R. G. Proliferative and lipid metabolism response to balloon angioplasty in canine renal arteries. J. Am. Coll. Cardiol 1990; 15: 1394–1400
   PubMed Web of Science ®Google Scholar
• Oseas R., Yang H.-H., Baehner R. L., Boxer L. A. Lactoferrin: A promoter of polymorphonuclear leukocyte adhesiveness. Blood 1981; 57: 939–945
   PubMed Web of Science ®Google Scholar
• Owens G. K., Geisterfer A. A. T., Yang Y. W.-H., Komoriya A. Transforming growth factor-β -induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J. Cell Biol 1988; 107: 771–780
   PubMed Web of Science ®Google Scholar
• Painter T. A. a) Myointimal hyperplasia: Pathogenesis and implications. 2. Animal injury models and mechanical factors. Artif. Organs 1991; 15: 103–118
   PubMed Web of Science ®Google Scholar
• Painter T. A. Myointimal hyperplasia: Pathogenesis and implications. 1.In vitro characteristics. Artif. Organs 1991b; 15: 42–55
   PubMed Web of Science ®Google Scholar
• Palabrica T., Lobb R., Furie BC., Aronovitz M., Benjamin C, Hsu Y.-M., Sajer S. A., Furie B. Leukocyte accumulation promoting fibrin deposition is mediatedin vivo by P-selectin on adherent platelets. Nature 1992; 359: 848–851
   PubMed Web of Science ®Google Scholar
• Palmberg L., Claesson H.-E., Thyberg J. Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells. J. Cell Sci. 1987; 88: 151–159
   PubMed Web of Science ®Google Scholar
• Palmer H., Libby P. Interferon-β: A potential autocrine regulator of human vascular smooth muscle cell growth. Lab. Invest. 1992; 66: 715–721
   PubMed Web of Science ®Google Scholar
• Parker-Botelho L., Cantor E. H., Ho E. H., Lumma W. C., Rubanyi G. M. Nitric oxide inactivates superoxide radicals produced by human leukocytes. (Abstract). Circulation 1989; 80: II–5
   Google Scholar
• Philips M., Juul A.-G., Thorsen S. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. Biochim. Biophys. Acta 1984; 802: 99–110
   PubMed Web of Science ®Google Scholar
• Pickering J. G., Bacha P., Jekanowski J., Weir L., Nichols J. C., Isner J. M. Prevention of smooth muscle cell proliferation and outgrowth from human atherosclerotic plaque by a recombinant fusion protein. (Abstract). Circulation 1992; 86: 1–226
   PubMedGoogle Scholar
• Piepgras D. G., Sundt T. M., Jr, Didisheim P. Effect of anticoagulants and inhibitors of platelet aggregation on thrombotic occlusion of endarterectomized cat carotid arteries. Stroke 1976; 7: 248–254
   PubMed Web of Science ®Google Scholar
• Piomelli D., Feinmark S. J., Cannon P. J. Leukotriene biosynthesis by canine and human coronary arteries. J. Pharmacol. Exp. Ther. 1987; 241: 763–770
   PubMed Web of Science ®Google Scholar
• Prescott S. M., Zimmerman G. A., McLntyre T. M. Human endothelial cells in culture produce platelet-activating factor (l-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc. Natl. Acad. Sci. USA 1984; 81: 3534–3538
   PubMed Web of Science ®Google Scholar
• Raines E. W., Dower S. K., Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243: 393–396
   PubMed Web of Science ®Google Scholar
• Rakugi H., Jacob H. J., Ingelfinger J. R., Krieger J. E., Dzau V. J., Pratt R. E. Angiotensinogen gene expression in the myointima after vascular injury. (Abstract). Hypertension 1990; 16: 345–346
   Web of Science ®Google Scholar
• Reidy M. A., Clowes A. W., Schwartz S. M. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab. Invest. 1983; 49: 569–575
   PubMed Web of Science ®Google Scholar
• Reis G. J., Pomerantz R. M., Jenkins R. D., Kuntz R. E., Bairn D. S., Diver D. J., Schnittt S. J., Safian R. D. Laser balloon angioplasty: Clinical, angiographic and histologic results. J. Am. Coll. Cardiol 1991; 18: 193–202
   PubMed Web of Science ®Google Scholar
• Rennick R. E., Campbell J. H., Campbell G. R. Vascular smooth muscle phenotype and growth behaviour can be influenced by macrophages in vitro. Atherosclerosis 1988; 71: 35–43
   PubMed Web of Science ®Google Scholar
• Ricevuti G., Mazzone A., Pasotti D., de Servi S., Specchia G. Role of granulocytes in endothelial injury in coronary heart disease in humans. Atherosclerosis 1991; 91: 1–14
   PubMed Web of Science ®Google Scholar
• Richardson M., Ihnatowycz I., Moore S. Glyco-saminoglycan distribution in rabbit aortic wall following balloon catheter deendothelialization: An ultrastructural study. Lab. Invest. 1980; 43: 509–516
   PubMed Web of Science ®Google Scholar
• Rifkin D. B., Moscatelli D., Bizik J., Quarto N., Blei F., Dennis P., Flaumenhaft R., Mignatti P. Growth factor control of extracellular proteolysis. Cell. Differ. Dev. 1990; 32: 313–318
   PubMedGoogle Scholar
• Ristimaki, Ylikorkala A. O., Viinikka L. Effect of growth factors on human vascular endothelial cell prostacyclin production. Arteriosclerosis 1990; 10: 653–657
   PubMedGoogle Scholar
• Ross R. The pathogenesis of atherosclerosis: An update. N. Engl. J. Med. 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Ross R., Masuda J., Raines E. W. Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis.Ann. N. Y. Acad. Sci. 1990a; 598: 102–112
   PubMed Web of Science ®Google Scholar
• Ross R., Masuda J., Raines E. W., Gown A. M., Katsuda S., Sasahara M., Maiden T., Masuko H., Sato H. Localization of PDGF-B protein in macrophages in all phases af atherogenesis. Science 1990b; 248: 1009–1012
   PubMed Web of Science ®Google Scholar
• Rossi V., Breviario F., Ghezzi P., Dejana E., Mantovani A. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 1985; 229: 174–176
   PubMed Web of Science ®Google Scholar
• Sachinidis A., Locher R., Hoppe J., Vetter W. The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett. 1990a; 275: 95–98
   PubMed Web of Science ®Google Scholar
• Sachinidis A., Locher R., Vetter W., Tatje D., Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J. Biol. Chem. 1990b; 265: 10238–10243
   PubMed Web of Science ®Google Scholar
• Saegusa Y. F, Cavender D., Ziff M. Stimulation of mononuclear cell binding to human endothelial cell monolayers by thrombin. J. Immunol. 1988; 141: 4140–4145
   PubMed Web of Science ®Google Scholar
• Safian R. D., Gelbfish J. S., Erny R. E., Schnitt S. J., Schmidt D. A., Bairn D. S. Coronary atherectomy: Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation 1990; 82: 69–79
   PubMed Web of Science ®Google Scholar
• Salvemini D., de Nucci G., Sneddon J. M., Vane J. R. Superoxide anions enhance platelet adhesion and aggregation. Br. J. Pharmacol. 1989; 97: 1145–1150
   PubMed Web of Science ®Google Scholar
• Saroyan R. M., Roberts M. P., Light J. T., Jr., Chen I.-L., Vaccarella M. Y., Bang D. J., Kvamme P., Singh S., Scalia S. V., Kerstein M. D., Kadowitz P. J., McNamara D. B. Differential recovery of prostacyclin and endothelium-derived relaxing factor after vascular injury. Am. J. Physiol. 1992; 262: H1449–H1457
   PubMed Web of Science ®Google Scholar
• Sato Y., Hamanaka R., Ono J., Kuwano M., Rifkin D. B., Takaki R. The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. Biochem. Biophys. Res. Commun. 1991; 174: 1260–1266
   PubMed Web of Science ®Google Scholar
• Schwartz S. M., Reidy M. A. Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Hum. Pathol. 1987; 18: 240–247
   PubMed Web of Science ®Google Scholar
• Schwartz R. S., Huber KC., Murphy J. G., Edwards W. D., Camrud A. R., Vlietstra R. E., Holmes D. R. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J. Am. Coll. Cardiol. 1992; 19: 267–274
   PubMed Web of Science ®Google Scholar
• Scott-Burden T., Schini V. B., Elizondo E., Junquero D. C., Vanhoutte P. M. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells: Effects on cell proliferation. Circ. Res. 1992; 71: 1088–1100
   PubMed Web of Science ®Google Scholar
• Seifert R. A., Schwartz S. M., PBowen-Ope D. F. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature 1984; 311: 669–671
   PubMed Web of Science ®Google Scholar
• Serruys P. W., Rutsch W., Heyndrickx G. R., Danchin N., Mast E. G., Wijns W., Rensing B. J., Vos J., Stibbe J. For the Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study Group (CARPORT). Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade: A randomized, double-blind, placebo-controlled trial. Circulation 1991a; 84: 1568–1580
   PubMed Web of Science ®Google Scholar
• Serruys P. W., Strauss B. H., Van Beusekom H M., Van der Giessen W. J. b) Stenting of coronary arteries: Has a modern Pandora's box been opened?. J. Am. Coll. Cardiol. 1991; 17: 143B–154B
   PubMed Web of Science ®Google Scholar
• Setty B. N. Y., Graeber J. E., Stuart M. J. The mitogenic effect of 15-and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition. J. Biol. Chem. 1987; 262: 17613–17622
   PubMed Web of Science ®Google Scholar
• Shaw J. O., Pinckard R. N., Ferrigni K. S., McManus L. M., Hanahan D. J. Activation of human neutrophils with l-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phoshphorylcholine (platelet activating factor). J. Immunol. 1981; 127: 1250–1255
   PubMed Web of Science ®Google Scholar
• Shepherd J. T., Vanhoutte P. M. Mechanisms responsible for coronary vasospasm. J. Am. Coll. Cardiol. 1986; 8: 50A–54A
   PubMed Web of Science ®Google Scholar
• Shirotani M., Yui Y., Hattori R., Kawai C. Serum from patients with restenosis after percutaneous transluminal coronary angioplasty stimulates proliferation of bovine vascular smooth muscle cells under low extracellular calcium condition. Jpn. Circ. J. 1991a; 55: 634–642
   PubMedGoogle Scholar
• Shirotani M., Yui Y., Hattori R, Kawai C. U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells. Prostaglandins 1991b; 41: 97–110
   PubMedGoogle Scholar
• Shirotani M., Hattori R., Kawai C, Sasayama S., Yui Y. HA1077: A new vasodilator that blocks intracellular actions of calcium. Cardiovasc. Drug. Rev. 1992; 10, in the press
   Google Scholar
• Simons M., Rosenberg R. D. Antisense nonmuscle myosin heavy chain andc-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ. Res. 1992; 70: 835–843
   PubMed Web of Science ®Google Scholar
• Simons M., Edelman E. R., DeKeyser J.-L., Langer R., Rosenberg R. D. Antisensec-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992; 359: 67–70
   PubMed Web of Science ®Google Scholar
• Sjölund M., Hedin U., Sejersen T., Heldin C.-H., Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype-and growth state-dependent manner. J. Cell Biol. 1988; 106: 403–413
   PubMed Web of Science ®Google Scholar
• Sneddon J. M., Vane R. Endothelium-derivedrelaxing factor reduces platelet adhesion to bovine endothelial cells. Proc. Natl. Acad. Sci. USA 1988; 85: 2800–2804
   PubMed Web of Science ®Google Scholar
• Snyderman R., Shin H. S., Hausman M. H. A chemotactic factor for mononuclear leukocytes. Proc. Soc. Exp. Biol. Med. 1971; 138: 387–390
   PubMed Web of Science ®Google Scholar
• Spagnuolo P. J., Ellner J. J., Hassid A., Dunn M. J. Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J. Clin. Invest. 1980; 66: 406–414
   PubMed Web of Science ®Google Scholar
• Speir E., Epstein S. E. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen. Circulation 1992; 86: 538–547
   PubMed Web of Science ®Google Scholar
• Stem D. M., Bank I., Nawroth P. P., Cassimeris J., Kisiel W., Fenton J. W., II, Dinarello C, Chess L., Jaffe E. A. Self-regulation of procoagulant events on the endothelial cell surface. J. Exp. Med. 1985; 162: 1223–1235
   PubMed Web of Science ®Google Scholar
• Stoll L. L., Spector A. A. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture. J. Cell. Physiol 1989; 139: 253–261
   PubMed Web of Science ®Google Scholar
• Strauss B. H., Serruys P. W., Bertrand M. E., Puel J., Meier B., Goy J.-J., Kappenberger L., Rickards A. F., Sigwart U. Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience - March 1986 to March 1990). Am. J. Cardiol. 1992; 69: 475–481
   PubMed Web of Science ®Google Scholar
• Sugama Y., Malik A. B. Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. Circ. Res. 1992; 71: 1015–1019
   PubMed Web of Science ®Google Scholar
• Tada T., Reidy M. A. Endothelial regeneration. IX. Arterial injury followed by rapid endothelial repair induces smooth-muscle-cell proliferation but not intimal thickening. Am. J. Pathol. 1987; 129: 429–433
   PubMed Web of Science ®Google Scholar
• Takehara K., LeRoy E. C., Grotendrost G. R. TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 1987; 49: 415–422
   PubMed Web of Science ®Google Scholar
• Tanimura N., Asada Y., Hayashi T., Kisanuki A., Sumiyoshi A. Aortic endothelial cell damage induced by β-VLDL and macrophages in vitro. Atherosclerosis 1990; 85: 161–167
   PubMed Web of Science ®Google Scholar
• Taubman M. B., Berk BC., Izumo S., Tsuda T., Alexander R. W., Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle: Role of Ca2+ mobilization and protein kinase C activation. J. Biol. Chem. 1989; 264: 526–530
   PubMed Web of Science ®Google Scholar
• Terranova V. P., DiFlorio R., Lyall R. M., Hie S., Friesel R., Maciag T. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J. Cell Biol. 1985; 101: 2330–2334
   PubMed Web of Science ®Google Scholar
• Thomas K. A., Rios-Candelore M., Gimenez-Gallego G., DiSalvo J., Bennett C, Rodkey J., Fitzpatrick S. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc. Natl. Acad. Sci. USA 1985; 82: 6409–6413
   PubMed Web of Science ®Google Scholar
• Ueda M., Becker A. E., Tsukada T., Numano F., Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty: An immunocytochemical analysis of the cellular composition. Circulation 1991; 83: 1327–1332
   PubMed Web of Science ®Google Scholar
• Valente A. J., Graves D. T., Vialle-Valentin C. E., Delgado R., Schwartz C. J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 1988; 27: 4162–4168
   PubMed Web of Science ®Google Scholar
• Vlodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J., Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 1987; 84: 2292–2296
   PubMed Web of Science ®Google Scholar
• Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor typeβ induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 1987; 84: 5788–5792
   PubMed Web of Science ®Google Scholar
• Walker L. N., Ramsay M. M., Bowyer D. E. Endothelial healing following defined injury to rabbit aorta: Depth of injury and mode of repair. Atherosclerosis 1983; 47: 123–130
   PubMed Web of Science ®Google Scholar
• Walker L. N., Bowen-Pope D. F., Ross R., Reidy M. A. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc. Natl. Acad. Sci. USA 1986; 83: 7311–7315
   PubMed Web of Science ®Google Scholar
• Warner S. J. C., Libby P. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J. Immunol 1989; 142: 100–109
   PubMed Web of Science ®Google Scholar
• Weich H. A., Iberg N., Klagsbrun M., Folkman J. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors 1990; 2: 313–320
   PubMed Web of Science ®Google Scholar
• Werns S. W., Lucchesi B. R. Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion. Free. Radic. Biol. Med. 1988; 4: 31–37
   PubMed Web of Science ®Google Scholar
• Whitworth H. B., Roubin G. S., Hollman J., Meier B., Leimgruber P. P., Douglas J. S., Jr, King S. B., III, Gruentzig A. R. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol 1986; 8: 1271–1276
   PubMed Web of Science ®Google Scholar
• Wilensky R. L., March K. L., Hathaway D. R. Direct intraarterial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty. Am. Heart J. 1991; 122: 1136–1140
   PubMed Web of Science ®Google Scholar
• Willems C. H., Astaldi G. C. B., De Groot G., Janssen MC., Gonsalvez M. D., Zeijlemaker W. P., Van Mourik J. A., Van Aken W. G. Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp. Cell. Res. 1982; 139: 191–197
   PubMed Web of Science ®Google Scholar
• Willerson J. T., Yao S.-K., Mc Natt J., Benedict C. R., Anderson H. V., Golino P., Murphree S. S., Buja L. M. Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc. Natl. Acad. Sci. USA 1991; 88: 10624–10628
   PubMed Web of Science ®Google Scholar
• Winkles J. A., Friesel R., Burgess W. H., Howk R., Mehlman T., Weinstein R., Maciag T. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc. Natl. Acad. Sci. USA 1987; 84: 7124–7128
   PubMed Web of Science ®Google Scholar
• Wolinsky H., Thung S. N. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J. Am. Coll. Cardiol. 1990; 15: 475–481
   PubMed Web of Science ®Google Scholar
• Wolinsky H., Lin C.-S. Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J. Am. Coll Cardiol 1991; 17: 174B–178B
   PubMed Web of Science ®Google Scholar
• Worthen G. S., Seccombe J. F., Clay K. L., Guthrie L. A., Johnston R. B., Jr. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor: Potential role in mediation of enhanced superoxide secretion. J. Immunol 1988; 140: 3553–3559
   PubMed Web of Science ®Google Scholar
• Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415
   PubMed Web of Science ®Google Scholar
• Zimmerman G. A., McLntyre T. M., Prescott S. M. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J. Clin. Invest. 1985; 76: 2235–2246
   PubMed Web of Science ®Google Scholar